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Abstract
 Limited laboratory capacity is a significant bottleneck in meetingBackground.
global targets for the control and elimination of neglected tropical diseases
(NTD). Laboratories are essential for providing clinical data and monitoring
data about the status and changes in NTD prevalence, and for detecting early
drug resistance. Currently NTD laboratory networks are informal and specialist
laboratory expertise is not well publicised, making it difficult to share global
expertise and provide training, supervision, and quality assurance for NTD
diagnosis and research. This study aimed to identify laboratories within five
World Health Organisation regions (South-East Asia, Eastern Mediterranean,
Americas, Western Pacific and Europe) that provide NTD services and could
be regarded as national or regional reference laboratories, and to conduct a
survey to document their networks and capacity to support NTD programmes.
 Potential NTD reference laboratories were identified throughMethods.
systematic searches, snowball sampling and key informants.
 Thirty-two laboratories responded to the survey. The laboratoriesResults.
covered 25 different NTDs and their main regional and national roles were to
provide technical support and training, research, test validation and standard
setting. Two thirds of the laboratories were based in academic institutions and
almost half had less than 11 staff. Although greater than 90 per cent of the
laboratories had adequate technical skills to function as an NTD reference
laboratory, almost all laboratories lacked systems for external verification that
their results met international standards.
 This study highlights that although  many laboratories believedConclusions.
they could act as a reference laboratory, only a few had all the characteristics
required to fulfil this role as they fell short in the standard and quality assurance
of laboratory processes. Networks of high quality laboratories are essential for
the control and elimination of disease and this study presents a critical first step
in the development of such networks for NTDs.
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Introduction
Laboratories are recognised as one of the weakest elements 
of health systems due to chronic under-investment. Lack of 
investment results in poor infrastructure, inadequate numbers 
and skills of technical staff, insufficient and uncoordinated 
technical assistance, and lack of diagnostic tools appropriate for 
low-resource settings1,2. Yet laboratory services are integral to 
interventions for the surveillance, control and elimination of 
neglected tropical diseases (NTDs). Laboratories provide clinical 
and monitoring data about disease prevalence and trends, and 
are essential for flagging up early signs of drug resistance1,3–6. 
Appropriate management of clinical cases of NTDs depends 
on laboratories providing accurate diagnoses for identifying 
cases5,6. Preventive chemotherapy interventions through mass 
drug administration (MDA) rely on laboratory data to make 
decisions regarding intervention effectiveness and for reliably 
documenting progress towards zero transmission5.
Accelerated scale-up of existing interventions is critical to reach 
the 2020 NTD Roadmap targets on the control and elimination 
of NTDs, however, lacking laboratory capacity is a critical 
bottleneck preventing the international NTD community from 
meeting targets. There needs to be enhanced laboratory ability 
in areas with significant NTD prevalence to provide technical 
and scientific support for the diagnosis, surveillance, monitoring 
and evaluation of national NTD programmes7. The World 
Health Organisation’s (WHO) Strategic and Technical Advisory 
Group (STAG) for Neglected Tropical Diseases have therefore 
prioritised strengthening the capacity of NTD laboratories 
and establishing a formal NTD laboratory network which can 
provide a quality assurance and referral function8. 
Globally, few laboratories specialise in NTDs. Laboratory support 
for NTD programmes is generally provided by parasitology 
laboratories within national health care systems or research 
institutions9. Most of these laboratories focus on malaria, and to 
a lesser extent on soil transmitted helminths (STH), with very 
little laboratory expertise in other NTDs10. No central register 
of specialist NTD laboratories exists. NTD laboratory exper-
tise is fragmented and un-coordinated, with no formal referral 
system or network to provide high level support from interna-
tionally-accredited reference laboratories for quality assurance of 
NTD testing. Consequentially, much laboratory data available on 
NTDs, that has been used to make important strategic decisions 
about programme implementation and transmission rates, may 
have been generated by laboratories working in isolation that 
are not enrolled in any external quality assurance scheme. The 
global laboratory infrastructure for NTD control programmes 
lags behind many other global health programmes, such as those 
for tuberculosis, malaria, poliomyelitis, measles and hepatitis, 
which successfully established a globally connected network 
of laboratories and systems for externally validating disease-
specific laboratory data as recommended by the World Health 
Assembly11,12.
To identify and harness existing capacity and to improve 
efficiency, laboratories that support national NTD programmes 
need to be mapped and organised into a functional international 
network. At the top tier, there should be internationally accredited 
and interlinked national reference laboratories. Each of 
which should head a pyramidal referral structure comprising 
laboratories at, for example, provincial level who support more 
peripheral district and primary care sites involved in front-line 
diagnosis and surveillance. The role of the NTD reference 
laboratories is to maintain their own accreditation and service 
quality, and to facilitate provision of quality services by lower 
level laboratories through, for example, offering training on good 
laboratory practice and quality management systems, external 
quality assessment and referral testing, and monitoring perform-
ance standards through the organisation of regular proficiency 
testing1.
Information about the location and expertise of laboratories 
with specialist NTD expertise across WHO regions is scarce and 
difficult to access. It is not generally known whether these 
laboratories meet international accreditation standards or have 
the capacity, expertise, and networks that would enable them 
to operate as national or regional reference centres. Creating a 
database of laboratories that includes a description of what 
support they can provide for NTD programmes is an essential 
first step in the process of establishing an international and 
regional NTD laboratory network.
This study aimed to identify laboratories that provide NTD 
services and could be regarded as national or regional reference 
laboratories within WHO regions, and to document their 
capacity to support NTD programmes. It covered five of WHO’s 
six regions since the WHO Africa region office conducted its 
own complementary study and the results could not be collated 
due to differing study methods. Our study mapped the 
geographical distribution and networks of these laboratories, and 
collated information about the skills and services they provided 
to support NTD programmes. Scoping the current situation 
provides a platform on which to design strategies to build an 
international network of accredited NTD reference laboratories. 
Such a network is essential to overcome the laboratory bottle-
neck which is a key barrier in accelerating intervention scale-up 
to meet 2020 NTD Roadmap goals7.
Methods
There is no existing global register of specialist NTD labora-
tories. This scoping study developed an unbiased and compre-
hensive way of identifying potential NTD reference laboratories 
in the five WHO regions – Americas, Eastern Mediterranean, 
Europe, South-East Asia and Western Pacific. As there was no pre- 
existing definition of an ‘NTD reference laboratory’, we extracted 
information from published literature13–17 about the laboratory 
characteristics needed to fulfil diagnostic, research, supervision, 
training, quality, and networking requirements of a national 
or regional reference laboratory for NTDs, and verified them 
with NTD control programme specialists. These characteristics 
were:
•    able to conduct verifiable quality diagnosis in one or 
more NTDs
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•    able to support research into NTDs prevalent in their region
•    able to train and mentor staff in national or tertiary level 
laboratories within the region
•    actively networked with other national and international NTD 
laboratories and research institutions
•    evidence of accreditation to international standards (e.g., ISO 
15189, Good Clinical Laboratory Practice (GCLP))
Detailed information from the literature about each of these 
characteristics was used to design an electronic survey admin-
istered through Bristol On-line Survey (now Online surveys) to 
laboratories in the five WHO regions with potential to be national 
or regional NTD reference laboratories. Topics covered were: 
location and geographical coverage, NTD tests available, 
accreditation status, staffing, ability to provide training and 
technical support, and any capacity gaps the laboratory perceived 
they had in relation to NTDs.
To identify as many potential regional reference laboratories 
to include in the survey, and to avoid bias, two wide-ranging 
search strategies were used. Firstly, key informants were 
identified from international NTD programmes and research 
institutions and through WHO regional offices. These included 
WHO officers in each of the five regions, representatives of 
multi-lateral agencies supporting laboratory networks and centres, 
and NTD funders and researchers. Snowballing was used to 
identify further key informants.
Each key informant was asked to identify which laboratories 
they were aware of that could be considered an NTD reference 
laboratory based on our pre-defined list of characteristics. 
Laboratories did not have to focus exclusively on NTDs, since 
NTDs may be part of a larger portfolio of work but needed to 
have a reputation as a referral laboratory (or laboratory unit) 
for NTDs. 25 key informants provided contact details for 69 
laboratories that they considered may be perceived as an NTD 
reference laboratory.
Secondly, an internet search for potential NTD reference 
laboratories was conducted. Countries affected by NTDs in each 
of the five WHO regions were identified from information on 
NTD strategies and/or activities in documents on WHO regional 
websites18–23, from country-specific information in the WHO 
NTD roadmap, and from individuals in the WHO Global 
Working Group on Capacity Strengthening for national NTD 
programmes. Overall 60 countries were identified as being 
affected by and prioritising NTDs in the five WHO regions: The 
Americas 17 countries, South-East Asia 11 countries, Europe 
8 countries, Eastern Mediterranean 14 countries, and Western 
Pacific 10 countries. Potential NTD reference laboratories were 
identified by searching websites of national NTD programmes 
in NTD-affected countries, and the websites of the WHO 
regional offices, and by following additional links and refer-
ences provided on these websites. The internet search strategy 
identified 98 laboratories that may potentially be NTD reference 
laboratories.
For each identified laboratory, contact details of laboratory heads 
were obtained from the websites or through key informants. 
Overall the combined searches yielded 167 contacts in potential 
reference laboratories. Each contact person was provided with 
information about the purpose and content of the survey by 
e-mail and asked to complete the survey. In order to increase 
response rates, the Modified Dillman approach24 was used which 
involved fortnightly reminders about the survey for a period of 
five weeks between October 2013-January 2014 until the survey 
closed. The survey was also offered in Spanish as appropriate. 
Following closure of the surveys, 35 telephone calls were made 
to collect information from non-respondents. These focussed 
particularly on the European and Americas regions due to low 
response rates and generated one additional completed survey.
Data from the survey was entered into an excel spreadsheet 
and anonymised. Data was analysed to provide quantitative, 
descriptive information, and content analysis was conducted to 
identify NTD laboratories that met or were close to meeting the 
characteristics of a reference laboratory. 
Results
Response rates and geographical coverage
Nineteen percent (n=32) of the 167 of the laboratory heads 
contacted responded to the survey. The majority of respond-
ents were from the Eastern Mediterranean region (34%, n=11) 
(Table 1). No responses were received from the European region. 
The majority of laboratories (53%, n=17) provided a national 
level service and 25% (n=8) operated at the international level, 
predominantly within their own WHO region. The main regional 
role of surveyed laboratories was the provision of technical 
support (22%, n=7) and training (22%, n=7) to other laboratories 
though some were also involved in research, test validation and 
standard setting (Table 1).
NTD specialisation
The 32 laboratories covered 25 different NTDs across five 
WHO regions with 23 laboratories (72%) covering two or more 
NTDs. Most laboratories within the Eastern Mediterranean 
region (73%, n=8) specialised in leishmaniasis. Within the 
Western Pacific region, laboratories tended to focus on STH (50%, 
n=4) and schistosomiasis (50%, n=4). Laboratories in South-
East Asia focused on STH (60%, n=6) and lymphatic filariasis 
(60%, n=6). Chagas disease, taeniasis, cysticercosis, echinococ-
cosis, onchocerciasis and dengue were the only NTDs covered 
in the Americas region.
Resources and capacities
Laboratories tended to be small with almost half (47 %, n=15) 
employing 1–10 staff and three-quarters (76%) employing 30 
or less. The South-East Asia region had the highest number of 
staff per laboratory. The Eastern Mediterranean region had the 
least staff and commonly lacked quality officers, management 
and administrative staff. Ninety one percent (n=29) of labora-
tories indicated that their staff had the necessary technical skills 
to function as an NTD reference laboratory and only one labora-
tory strongly believed it lacked this technical capacity. Two thirds 
(69%, n=22) of the laboratories were based in academic institutions 
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Table 1. Characteristics and distribution of potential 
neglected tropical disease (NTD) reference 
laboratories.
Main characteristics Laboratories 
n=32 (%)
Laboratory location (by WHO region)
Eastern Mediterranean 11 (34)
South-East Asia 10 (31)
Western Pacific 8 (25)
The Americas 3 (9)
Europe 0 (0)
Geographical coverage
National 17 (53)
International 8 (25)
Sub-national 7 (22)
Regional Role
Technical support to other laboratories 7 (22)
Providing training for other laboratories 7 (22)
Developing, validating and testing NTD 
methods and protocols
5 (16)
Advising on, and meeting, NTD 
research needs
5 (16)
Taking part in standardization on 
accreditation and certification
2 (6)
Other 6 (19)
Total number of staff in the laboratory
1–10 15 (47)
11–30 9 (29)
31–50 3 (9)
More than 50 5 (16)
Self-identified capacity gaps
Lack of external Quality Assurance 9 (28)
Insufficient capacity to provide technical 
support
4 (13)
Insufficient expertise to conduct quality 
control of laboratory activities linked to 
NTDs
3 (9)
Insufficient capacity to conduct NTD 
diagnostics
3 (9)
Insufficient capacity to conduct NTD 
research
3 (9)
Insufficient capacity to support staff 
training
2 (6)
Inability to promote strategic plan 1 (3)
Insufficient funds 1 (3)
Insufficient human resource 1 (3)
None 5 (16)
and felt they were strong in supporting NTD research. 
The majority of laboratories (78 %, n=25) identified at least one 
gap in their capacity, most commonly external quality assurance, 
which was reported as lacking by 9 (28%) laboratories. The type 
of capacity gaps was similar across all five regions.
International standards, quality assurance for NTD testing 
and networks
There was variation in adherence to laboratory quality standards. 
Only four (13%) stated adherence to international standards 
such as Good Laboratory Practice, ISO 15189 and ISO 9000. 
47 percent (15) of laboratories adhered to national quality 
standards and 40% (13) did not adhere to any. Although 47% 
(19) of laboratories reported a quality officer, only five (16%) 
participated in an external quality assurance (EQA) programme 
for NTD tests. Four of these were in the Eastern Mediterranean 
region. All five stated that less than 5% of their results within the 
last 3 years had been unsatisfactory. In the Western Pacific, 
South-East Asia and Americas regions, at least 90% (12) of 
laboratories did not participate in an external quality assurance 
scheme. Fourteen (44%) laboratories had regular interactions 
with international NTD networks including Drugs for Neglected 
Diseases Initiative, Tropical Disease Research and regional 
NTD elimination programmes. International conferences, regional 
meetings, and NTD workshops, were the predominant modes 
of networking reported. Despite the majority (91%) of labora-
tories believing they have the capacity to carry out the role of a 
reference laboratory, only 14% (n=3) met all the pre-determined 
characteristics.
Dataset 1. De-identified survey data
http://dx.doi.org/10.5256/f1000research.16196.d217501
Conclusions
This study marks an important step in a process towards 
creating the need and awareness for an international network 
of NTD expert laboratories. We used a systematic and wide- 
ranging approach to identify 32 laboratories distributed across 
four of five WHO regions which have potential to be regional 
or national reference laboratories for NTDs. Between them, 
these laboratories reported that they have the technical skills to 
provide expertise in 25 different NTDs with each laboratory 
focussing on NTDs that are prevalent in their region. These 
laboratories could form the top tier of an interlinked network of 
laboratories capable of providing quality information for NTD 
programmes and able to act as NTD research and training 
centres. Half the laboratories operated at national level and a 
quarter at regional level and this two-level geographical focus 
forms a sound basis for creating national and international NTD 
laboratory networks.
Although over 90% of the laboratories surveyed in this study 
believed they could act as a reference laboratory, only 3 had all 
the characteristics required to fulfil this role. Almost all labora-
tories fell short in the area of standards and quality assurance of 
laboratory processes. A consistent finding was that 87% of 
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laboratories did not adhere to international quality standards and 
40% did not adhere to national quality standards. Further evidence 
of the paucity of quality systems is that only five of the 32 labo-
ratories participated in an EQA programme for NTD tests; four 
of these were in the Eastern Mediterranean region. This means 
there is no independent verification that laboratory results meet 
international standards. Such verification is imperative in order 
to generate reliable results and lack of verification undermines 
confidence in data concerning NTD prevalence, trends and 
reduced drug efficacy25. Unless NTD data originates from quality 
assured, accredited laboratories, reports about progress towards 
global NTD targets will lack credibility.
It is not clear why laboratories felt that they were able to act 
as reference laboratories even though many did not adhere to 
national or international quality standards and most were not 
enrolled in external quality schemes. This finding suggests that 
the importance of being able to demonstrate that test results are 
reliable may be under-recognised even among laboratory 
professionals and that this validation is not demanded by NTD 
programme managers and other decision makers.
Limitations 
Overall, we contacted 167 laboratories and received infor-
mation from 32, a third of which were located within the 
Eastern Mediterranean region; none were in the European region. 
We used a broad search strategy, so a high response rate was not 
anticipated since it was likely that many laboratories contacted 
were not involved in reference-level NTD work. However, it is 
possible that our search missed some relevant laboratories or that 
we did not identify some laboratories because contact details were 
incorrect, or language barriers prevented some managers from 
responding. 
Recommendations
The majority of laboratories covered at least two different 
NTDs. This diversity raises an important question about whether 
each laboratory should focus on one NTD or several. This 
will in part be dictated by existing expertise and by the bur-
den of different NTDs in the vicinity. The most efficient use 
of resources may be to centralise expertise for several NTDs 
within one laboratory. This would facilitate throughput of large 
numbers of samples and centralise the expensive, state-of-the-
art diagnostic tools needed to provide high levels of diagnostic 
specificity and sensitivity26–28. Amalgamation of laboratory 
services for several NTDs is complex and would need to be 
carefully managed to maintain rigorous systems and quality 
standards across a large range of services and to get buy-in from 
national programme managers and other laboratories25.
Most of the laboratories specialising in NTDs are based in 
research institutions. This is an important factor to consider when 
planning an international NTD laboratory network since the 
primary goal of these laboratories is to generate research. This 
goal may not always be aligned with the priorities of national 
NTD programmes to provide routine service delivery and training. 
Research laboratories are characterised by short-term projects 
with high staff turnover and are strongly influenced by the topical 
interests of donors. The difference in priorities faced by research 
laboratories and NTD programmes means that potential ten-
sions need to be anticipated and managed if a research laboratory 
is the primary provider of national or regional NTD laboratory 
expertise.
Although only three of the identified laboratories had all the 
characteristics of a reference laboratory, within each of the four 
WHO regions surveyed there are at least two laboratories that could 
be strengthened to reach international accreditation status and 
fulfil a role as a regional reference centre for NTDs. Responses 
from these laboratories indicated they have some experience 
in implementing international laboratory standards, in using 
advanced diagnostic tools and in providing technical support 
and training to other laboratories. At least some of the surveyed 
laboratories have the potential to be in the top global tier as 
regional reference laboratories once they are able to adhere 
to international quality standards. If they are integrated into a 
formal laboratory network, they will be able to, for example, 
share equipment, develop standardised indicators and regu-
lar monitoring protocols for laboratory performance and staff 
competence29, and provide training, supervision and mentoring 
for lower tier laboratories.
This study provides preliminary information about the location 
and expertise of high-level laboratories specialising in NTDs. 
The data we collected was self-reported by laboratory person-
nel, so an important next step will be for additional information 
from European and African NTD laboratories to be incorporated, 
and for selected laboratories to undergo a more in-depth and 
independent assessment of their capacity. Criteria then need 
to be agreed and used to strategically select a small number of 
laboratories in each region which will be supported techni-
cally and financially to achieve international accreditation and 
formal recognition as regional NTD reference laboratories. These 
laboratories can then form foci around which to construct a 
global network of NTD laboratories with the longer term aim 
of encompassing national and sub-national laboratories within 
the network. A wide-ranging stakeholder consultation process, 
likely conducted under the stewardship of the NTD STAG which 
reports directly to the Director General of WHO, will be needed 
to define the criteria for selecting laboratories and to define the 
goal and operation of the NTD laboratory network30. Only when 
this laboratory network is operational will it be possible to have 
effective and rapid regional and global referral and quality 
assurance systems and to have confidence in the NTD test results 
that are essential to support NTD programme operations and 
research needs 12,27. 
Data availability
Dataset 1: De-identified survey data 10.5256/f1000research.16196.
d21750131
Consent
Potential participants were informed about the purpose and con-
tent of the survey and could choose whether or not to complete the 
survey.
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